"On November 27, 2018, the Company confidentially filed a Regulation A+ offering (the “Reg A”) with the U.S. Securities and Exchange Commission (the “SEC”) to raise a maximum of $20,000,000 in common stock at a fixed price of between $0.01 and $1 per share. The Company received comments on the Reg A from the SEC on December 21st, 2018. The Company expects to respond to those comments early in the first quarter of 2019. The final per share price of the Reg A offering will be determined by Amarantus management immediately prior to the offering becoming qualified and open for investment."
Looks as if Gerald is planning on sooner rather than later.
Aloha
(2)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links